Patrick Bilbo is responsible for Organogenesis’ Regulatory Affairs, Government Relations and Healthcare Compliance departments. He has more than 20 years of experience in the medical products industry, with a broad range of expertise in the commercialization of transformational devices, combination products and regenerative medicine therapies. Throughout his career he has held positions in regulatory affairs, clinical research and product development, and at Organogenesis has focused on successfully overcoming the unique challenges of developing living cell-based products for large scale patient use. Previously he held management and research positions at Cytyc Corporation (Hologic), Stryker Corporation (Biotech Division) and the Cell Biology Department at Harvard Medical School. Mr. Bilbo earned his M.B.A. degree from the Boston University Graduate School of Management, Masters degrees in Cell Biology and Technology Strategy/Policy from the Boston University Graduate School of Arts & Sciences, and a B.S. degree in Biology from Syracuse University.